Discovery Life Sciences, a leading research biobank located in Los Osos, California, recently got much larger via a four-company merger. Ann Dover, Discovery’s founder, president and CEO, spoke with BioSpace about the merger and biobank’s new identity.
Sanofi is reportedly eying a significant expansion in Cambridge, Mass., that could spur a hiring spree. In Portland, Oregon, Genentech is looking to open an office space that would require up to 300 new hires, The Portland Business Journal reported.
The U.S. Food and Drug Administration approved Pfizer Inc.’s Talzenna (talazoparib) for an advanced form of breast cancer.
Rival versions of the world’s top-selling drug – AbbVie’s Humira – went on sale in Europe, years ahead of similar cut-price copies being available in the United States.
Johnson & Johnson reported slightly better-than-expected third-quarter 2018 profit and raised the company’s full-year forecast.
Drugmakers Sanofi and Regeneron received positive results for Dupixent, which treats eczema and is seen as a key driver of future revenues.
The U.S. government, in an effort to increase pressure on drugmakers to lower costs for U.S. consumers, will propose requiring companies to include the price of Rx medicines in TV ads.
AstraZeneca will keep the company’s freeze on manufacturing investments in Britain if the country’s exit from the European Union fails to give enough clarity on future trading relations, the drugmaker’s chairman was quoted as saying.
Up to 10,000 Americans due to have hip or knee replacements will be able to funnel basic health data directly from their Apple Watches to their surgeons under a new app being tested by prosthetic limb specialist Zimmer Biomet.
Novo Nordisk is in advanced talks to acquire assets to bolster the company’s struggling biopharma business after the drugmaker announced the hiring of an AstraZeneca executive to head the unit.
Watertown, Mass.-based SQZ Biotechnologies could be on the receiving end of up to $1 billion following the company’s signing of an expansion agreement with pharma giant Roche.
The U.S. Food and Drug Administration’s Anesthetic and Analgesic Drug Products Advisory Committee voted to recommend AcelRx Pharmaceuticals’ Dsuvia to manage moderate-to-severe pain.
Emeryville, Calif.-based Berkeley Lights closed on a $95 million financing round, led by Nikon.
International aid financing and innovation has helped to save nearly 700 million lives in the past 25 years, but those gains could be lost if momentum and political will wane, global health experts said.
Forbes’ 2018 ranking of the “World’s Best Employers” includes a number of global biopharmaceutical companies.
Researchers at Johns Hopkins University, the University of California, San Diego (UCSD), and the National Institute of Mental Health grew retinas in Petri dishes and discovered fundamental factors involved in the development of vision and color vision.
A U.S. appeals court upheld a ruling that canceled patents owned by Teva Pharmaceutical Industries Ltd. on the blockbuster multiple sclerosis drug Copaxone.
Bristol-Myers Squibb’s blockbuster cancer drug Opdivo failed to meet the main goal in a late-stage trial on patients with a type of lung cancer, whose condition had relapsed after chemotherapy.
AbbVie Inc. settled all patent disputes with Novartis AG, granting the Swiss drugmaker a non-exclusive license to manufacture and sell a copycat version of the blockbuster drug Humira.
A New Jersey jury cleared J&J of liability in a case involving a woman who alleged that the company’s talc-based products, including baby powder, contain asbestos and caused her cancer.